The effect of cyproheptadine on pediatric growth
Not Applicable
- Conditions
- Failure to thrive.Other lack of expected normal physiological development
- Registration Number
- IRCT201201268827N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
children aged between2 to 5 years old and have mild to moderate failure to thrive.
Exclusion criterion: Having organic causes or acute or chronic diseases.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight. Timepoint: At begining of study, 1 month after begining and 1 month after termination of study. Method of measurement: Kilogram.;Height. Timepoint: At begining of study, 1 month after begining and 1 month after termination of study. Method of measurement: Cm.
- Secondary Outcome Measures
Name Time Method Drowsiness. Timepoint: During drug consumption. Method of measurement: History and Physical examination.;Restlessness. Timepoint: During drug consumption. Method of measurement: History and Physical Examination.